Trials / Active Not Recruiting
Active Not RecruitingNCT03320252
Endurant CHevAr New Indication Trial: ENCHANT
Endurant CHevAr New Indication Trial: ENCHANT - Post-market Study of the Endurant CHEVAR Technique for the Treatment of Juxtarenal Aortic Aneurysms With a Short Infrarenal Neck
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Medtronic Cardiovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the post-market study is to assess the clinical outcomes, safety, and performance of the Endurant Chimney Graft Technique (Endurant Stent Graft Systems used with a balloon-expandable covered stent graft) for treatment of juxtarenal aortic aneurysms with a short infrarenal neck in a real world setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endurant Chimney Graft Technique | Medtronic Endurant II and Endurant IIs Stent Graft Systems and balloon-expandable covered stent graft systems approved for use in the renal arteries. These devices will be utilized in a chimney graft configuration. |
Timeline
- Start date
- 2017-10-26
- Primary completion
- 2026-03-01
- Completion
- 2030-07-01
- First posted
- 2017-10-25
- Last updated
- 2025-09-18
Locations
26 sites across 13 countries: Austria, France, Germany, Greece, Italy, Netherlands, Portugal, Russia, Slovakia, Spain, Sweden, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT03320252. Inclusion in this directory is not an endorsement.